FDA.reportPublic FDA data

Application 208358

Type
ANDA
Sponsor
CADILA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TRIAMTERENE AND HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE; TRIAMTERENECAPSULE;ORAL25MG;37.5MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
60760-783Triamterene and HydrochlorothiazideTriamterene and HydrochlorothiazideSt Mary's Medical Park PharmacyANDACurrent
68071-2533Triamterene and HydrochlorothiazideTriamterene and HydrochlorothiazideNuCare Pharmaceuticals,Inc.ANDACurrent
68382-855Triamterene and HydrochlorothiazideTriamterene and HydrochlorothiazideZydus Pharmaceuticals (USA) Inc.ANDACurrent
70771-1474Triamterene and HydrochlorothiazideTriamterene and HydrochlorothiazideCadila Healthcare LimitedANDACurrent
70771-1474Triamterene and HydrochlorothiazideTriamterene and HydrochlorothiazideCadila Healthcare LimitedANDACurrent
71335-2034Triamterene and HydrochlorothiazideTriamterene and HydrochlorothiazideBryant Ranch PrepackANDACurrent
72578-090Triamterene and HydrochlorothiazideTriamterene and HydrochlorothiazideViona Pharmaceuticals IncANDACurrent
72578-090Triamterene and HydrochlorothiazideTriamterene and HydrochlorothiazideViona Pharmaceuticals IncANDACurrent
72578-090Triamterene and HydrochlorothiazideTriamterene and HydrochlorothiazideViona Pharmaceuticals IncANDACurrent